Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
10 May, 2026, 08.50 AM IST
US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
05 May, 2026, 09.04 PM IST
US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
17 Apr, 2026, 11.46 PM IST
Trump administration readies new tariffs on select drugmakers: ReportThe Trump administration is reportedly preparing to impose 100% tariffs on drugmakers that haven't secured deals for lower U.S. prices. Sev...
02 Apr, 2026, 08.24 AM IST
Pfizer to acquire obesity drug startup Metsera in $10 billion dealPfizer has agreed to acquire obesity drug developer Metsera for up to $86.25 a share, surpassing Novo Nordisk's final offer. This move mark...
10 Nov, 2025, 12.25 AM IST
Pfizer weighs sweeter offer for Metsera after Judge blocks bid to halt Novo Nordisk’s $10 billion takeoverPfizer is increasing its offer for Metsera. This comes after a judge rejected Pfizer's attempt to stop rival Novo Nordisk's bid. Pfizer's d...
06 Nov, 2025, 07.09 AM IST
Banquets and billions: How AstraZeneca sealed a US medicine deal with TrumpAstraZeneca CEO Pascal Soriot met with U.S. President Donald Trump to finalize a medicine deal. This agreement will lower drug prices for m...
13 Oct, 2025, 12.48 PM IST
US Pfizer deal powers European health stocks as Trump policy haze clearsEuropean healthcare stocks jumped on Wednesday, mirroring moves in the United States, propelled by a deal between Pfizer and President Dona...
01 Oct, 2025, 08.12 PM IST
PFE stock rises 5.3% today: Pfizer seals Trump drug price deal with $70 billion U.S. investment and $7.3 billion Metsera weight-loss acquisitionPfizer Inc. (NYSE: PFE) experienced a significant uptick in its stock price following two major announcements on September 30, 2025. Presid...
30 Sep, 2025, 10.26 PM IST
Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera: ReportPfizer is close to acquiring Metsera, an anti-obesity drug developer. The deal could be worth $7.3 billion. Pfizer will pay $47.50 per shar...
22 Sep, 2025, 11.14 AM IST
Pfizer to buy Allergan in $160 billion deal to create world's No 1 drugmakerNew York-based Pfizer and Allergan, headquartered in Ireland, said on Monday that Pfizer would offer 11.3 of its own shares for each Allerg...
24 Nov, 2015, 04.51 PM IST
Pfizer, allergan in talks to forge $330bn giant: WSJA bid for Allergan would be Pfizer's second attempt to acquire a European rival, following its unsuccessfully courtship of AstraZeneca Plc.
30 Oct, 2015, 04.20 AM IST
- Biocon's corporate governance standards raise alarm among analysts
Research firm ESPIROTO SANTO Investment bank has questioned the accounting practise of Bangalore based biotechnology company Biocon.
23 May, 2012, 02.46 PM IST
- Bicon stock can be a really good performer: Pankaj Pandey, ICICI Direct
Over the last few days, the developments have been quite positive in Biocon.
22 Oct, 2010, 05.20 PM IST
- Pfizer deal shot in arm for Biocon
As per the deal, Biocon will conduct clinical development and regulatory filings while Pfizer will get the exclusive rights to market these...
20 Oct, 2010, 12.55 AM IST
- Pfizer to license generics from India's Aurobindo
Pfizer Inc has agreed to license an array of generic pills and injectable medicines from India's Aurobindo Pharma Ltd as the world's larges...
03 Mar, 2009, 02.31 PM IST
- Reports: Pfizer, Wyeth said to be close to deal
Pfizer and Wyeth are closing in on a deal worth $68 billion that could be announced before the markets open Monday.
26 Jan, 2009, 09.03 AM IST